Bryce A. Roberts
Gründer bei Arbutus Biopharma, Inc.
Aktive Positionen von Bryce A. Roberts
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Verwaltungsdirektor | 01.05.2012 | - |
| Gründer | 01.05.2012 | - | |
| General Counsel | 01.05.2012 | - |
Karriereverlauf von Bryce A. Roberts
Ehemalige bekannte Positionen von Bryce A. Roberts
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | - | - |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | General Counsel | - | - |
| Unternehmenssekretär | - | 13.01.2012 |
Ausbildung von Bryce A. Roberts
| Georgia State University College of Law | Graduate Degree |
| University of Georgia | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| General Counsel | 3 |
| Corporate Secretary | 1 |
| Chief Administrative Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
- Börse
- Insiders
- Bryce A. Roberts
- Erfahrung
